Evidence map›Paper›PMID 23262781›Full record

ArticleNanoscale2013

Nanoscale analysis of caspofungin-induced cell surface remodelling in Candida albicans.

Sofiane El-Kirat-Chatel, Audrey Beaussart, David Alsteens, Desmond N Jackson, Peter N Lipke, Yves F Dufrêne

Abstract read
In one paragraph

Article in Nanoscale, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Caspofungin resistance in Candida albicans: genetic factors and synergistic compounds for combination therapies.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022
    Review
  7. Article
  8. Article
  9. Back to Nature: CombatingAntibiotics (Basel, Switzerland) · 2021
    Article
  10. Review
  11. mSphere · 2020
    Article
  12. Article
  13. How Microbes Use Force To Control Adhesion.Journal of bacteriology · 2020
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Fungal biology and biotechnology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Sofiane El-Kirat-ChatelUniversité catholique de Louvain, Institute of Life Sciences & Institute of Condensed Matter and Nanosciences, Croix du Sud, 1, bte L7.04.01., B-1348 Louvain-la-Neuve, Belgium.
Audrey Beaussart
David Alsteens
Desmond N Jackson
Peter N Lipke
Yves F Dufrêne
UCLouvain · BEBrooklyn College · USCity University of New York · US

Funding

Amyloid-like Interactions in Yeast Cell AdhesionSC1GM083756 · NIGMS · BROOKLYN COLLEGE · PI LIPKE, PETER N · 2008 to 2011
$1.7M
Diversity Supplement to R01 GM 098616 for Ivor JosephR01GM098616 · NIGMS · BROOKLYN COLLEGE · PI LIPKE, PETER N · 2012 to 2015
$1.5M
NIGMS NIH HHS R01 GM098616NIGMS NIH HHS SC1 GM083756
6 · The paper itself

Abstract

The advent of fungal pathogens that are resistant to the classic repertoire of antifungal drugs has increased the need for new therapeutic agents. A prominent example of such a novel compound is caspofungin, known to alter cell wall biogenesis by inhibiting β-1,3-D-glucan synthesis. Although much progress has been made in understanding the mechanism of action of caspofungin, little is known about its influence on the biophysical properties of the fungal cells. Here, we use atomic force microscopy (AFM) to demonstrate that caspofungin induces major remodelling of the cell surface properties of Candida albicans. Caspofungin causes major morphological and structural alterations of the cells, which correlate with a decrease of the cell wall mechanical strength. Moreover, we find that the drug induces the massive exposure of the cell adhesion protein Als1 on the cell surface and leads to increased cell surface hydrophobicity, two features that trigger cell aggregation. This behaviour is not observed in yeast species lacking Als1, demonstrating the key role that the protein plays in determining the aggregation phenotype of C. albicans. The results show that AFM opens up new avenues for understanding the molecular bases of microbe-drug interactions and for developing new therapeutic agents.

Indexed as

Antifungal AgentsCandida albicansCaspofunginCell MembraneEchinocandinsLipopeptidesMembrane FluidityMicroscopy, Atomic ForceNanostructuresAntifungal AgentsCaspofunginEchinocandinsLipopeptides

Identifiers

PMID23262781
PMCPMC3564254
OpenAlexW2005149112

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.